Company Profile
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Our strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VC Institutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, we have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion. We have taken many years in the business and raised the core concept of 'taking entrepreneurs as the center and value creators as the basis'. With this concept, we have built an experienced and featured professional investment team. EFUNG also persists in a systematic operation that integrates investment, financing, risk control, management, and service. We have the confidence to become a well-grounded, people-oriented and trustworthy investment institution.
                Development Path                               
<
  • 2001
    2001
    The founder of Efung Captital invested Mindray Medical
  • 2007
    2007
    Efung Captital was officially established and had formed a professional investment team.
  • 2012
    2012
    Transformed into a life-science focused venture capital firm.
  • 2014
    2014
    Raised and invested the first fund.
  • 2015
    2015
    Started the research and analysis of oversea pharmaceutical and healthcare industry.
  • 2017
    2017
    Raised and invested the first USD fund.
  • 2019
    2019
    Over 20 portfolio companies worldwide .
>
Advantages
——
——
Professional
——
——
Focused
——
——
Resourceful
——
——
Strategic
——
——
Collaborative
——
——
Prudent
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务
进入手机网站